Christopher J. Halbrook

6.7k total citations · 3 hit papers
25 papers, 2.7k citations indexed

About

Christopher J. Halbrook is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Christopher J. Halbrook has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Christopher J. Halbrook's work include Pancreatic and Hepatic Oncology Research (15 papers), Epigenetics and DNA Methylation (6 papers) and Phagocytosis and Immune Regulation (5 papers). Christopher J. Halbrook is often cited by papers focused on Pancreatic and Hepatic Oncology Research (15 papers), Epigenetics and DNA Methylation (6 papers) and Phagocytosis and Immune Regulation (5 papers). Christopher J. Halbrook collaborates with scholars based in United States, Germany and Netherlands. Christopher J. Halbrook's co-authors include Costas A. Lyssiotis, Marina Pasca di Magliano, Anirban Maitra, Li Zhang, Daniel M. Kremer, Xiaoxu Wang, Alec C. Kimmelman, Lewis C. Cantley, Douglas E. Biancur and Rosa F. Hwang and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Christopher J. Halbrook

25 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

2016 813 citations Christopher J. Halbrook, Li Zhang et al. profile →
Pancreatic cancer: Advances and challenges

2023 599 citations Christopher J. Halbrook, Costas A. Lyssiotis et al. Cell profile →
Arginase 1 is a key driver of immune suppression in pancreatic cancer

2023 96 citations Rosa E. Menjivar, Zeribe C. Nwosu et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Halbrook United States	17	1.5k	1.2k	958	466	377	25	2.7k
Tao Yin China	31	1.6k 1.1×	1.1k 0.9×	756 0.8×	377 0.8×	177 0.5×	89	2.7k
Ya’an Kang United States	31	2.2k 1.5×	1.4k 1.2×	1.7k 1.7×	576 1.2×	445 1.2×	53	3.9k
Patricia Sancho Spain	33	2.5k 1.7×	1.4k 1.2×	1.3k 1.3×	608 1.3×	371 1.0×	61	4.0k
Go J. Yoshida Japan	21	1.5k 1.0×	931 0.8×	949 1.0×	248 0.5×	221 0.6×	25	2.5k
Shunrong Ji China	33	1.9k 1.3×	1.4k 1.1×	1.2k 1.2×	275 0.6×	420 1.1×	110	3.2k
Douglas E. Biancur United States	16	1.8k 1.2×	1.1k 0.9×	1.2k 1.3×	671 1.4×	852 2.3×	18	3.5k
Paloma Bragado Spain	21	1.5k 1.0×	1.7k 1.3×	956 1.0×	386 0.8×	234 0.6×	48	3.1k
Houjie Liang China	29	1.2k 0.8×	711 0.6×	881 0.9×	340 0.7×	157 0.4×	73	2.4k
Parthasarathy Seshacharyulu United States	29	1.7k 1.2×	1.1k 0.9×	595 0.6×	435 0.9×	144 0.4×	53	2.9k
José M.A. Moreira Denmark	31	1.8k 1.2×	656 0.5×	670 0.7×	239 0.5×	147 0.4×	79	2.8k

Countries citing papers authored by Christopher J. Halbrook

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Halbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Halbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Halbrook more than expected).

Fields of papers citing papers by Christopher J. Halbrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Halbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Halbrook. The network helps show where Christopher J. Halbrook may publish in the future.

Co-authorship network of co-authors of Christopher J. Halbrook

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Halbrook. A scholar is included among the top collaborators of Christopher J. Halbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Halbrook. Christopher J. Halbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alcolea, Maria P., Direna Alonso‐Curbelo, Chiara Ambrogio, et al.. (2024). Cancer Hallmarks: Piecing the Puzzle Together. Cancer Discovery. 14(4). 674–682. 7 indexed citations

Shan, Mengrou, Megan D. Radyk, Christopher J. Halbrook, et al.. (2024). Malic enzyme 1 knockout has no deleterious phenotype and is favored in the male germline under standard laboratory conditions. PLoS ONE. 19(6). e0303577–e0303577. 2 indexed citations

Lim, Rebecca, et al.. (2024). CARMIL1-AA selectively inhibits macropinocytosis while sparing autophagy. Molecular Biology of the Cell. 36(1). ar4–ar4. 3 indexed citations

Menjivar, Rosa E., Zeribe C. Nwosu, Wenting Du, et al.. (2023). Arginase 1 is a key driver of immune suppression in pancreatic cancer. eLife. 12. 96 indexed citations breakdown →

Halbrook, Christopher J., Costas A. Lyssiotis, Marina Pasca di Magliano, & Anirban Maitra. (2023). Pancreatic cancer: Advances and challenges. Cell. 186(8). 1729–1754. 599 indexed citations breakdown →

Lee, Ho‐Joon, Nina G. Steele, Li Zhang, et al.. (2022). Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF–PI3K pathway. eLife. 11. 38 indexed citations

Krall, Abigail S., Peter J. Mullen, Milica Momcilovic, et al.. (2021). Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metabolism. 33(5). 1013–1026.e6. 177 indexed citations

Zhou, Zhangsen, Mauricio Torres, Haibo Sha, et al.. (2020). Endoplasmic reticulum–associated degradation regulates mitochondrial dynamics in brown adipocytes. Science. 368(6486). 54–60. 147 indexed citations

Lanfranca, Mirna Perusina, Yaqing Zhang, Alexander A. Girgis, et al.. (2019). Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. Gastroenterology. 158(5). 1417–1432.e11. 61 indexed citations

10.

Wang, Lidong, Huibin Yang, Andrea Zamperone, et al.. (2019). ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. Genes & Development. 33(11-12). 641–655. 21 indexed citations

11.

Menjivar, Rosa E., Christopher J. Halbrook, Fatima Lima, et al.. (2019). Abstract A31: Investigating the effect of myeloid Arg1 deletion on tumor growth and CD8+ T-cell infiltration and activation in pancreatic cancer. Cancer Research. 79(24_Supplement). A31–A31. 2 indexed citations

12.

Lanfranca, Mirna Perusina, Joyce K. Thompson, Filip Bednar, et al.. (2018). Metabolism and epigenetics of pancreatic cancer stem cells. Seminars in Cancer Biology. 57. 19–26. 45 indexed citations

13.

Halbrook, Christopher J., Marina Pasca di Magliano, & Costas A. Lyssiotis. (2018). Tumor cross-talk networks promote growth and support immune evasion in pancreatic cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology. 315(1). G27–G35. 14 indexed citations

14.

Svoboda, Laurie K., Sudha Sud, Samuel A. Kerk, et al.. (2018). Menin regulates the serine biosynthetic pathway in Ewing sarcoma. The Journal of Pathology. 245(3). 324–336. 41 indexed citations

15.

Schofield, Heather, Christopher J. Halbrook, Sadeesh K. Ramakrishnan, et al.. (2017). Pancreatic HIF2α Stabilization Leads to Chronic Pancreatitis and Predisposes to Mucinous Cystic Neoplasm. Cellular and Molecular Gastroenterology and Hepatology. 5(2). 169–185.e2. 11 indexed citations

16.

Halbrook, Christopher J. & Costas A. Lyssiotis. (2017). Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. Cancer Cell. 31(1). 5–19. 271 indexed citations

17.

Halbrook, Christopher J., et al.. (2016). Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis. Cellular and Molecular Gastroenterology and Hepatology. 3(1). 99–118. 39 indexed citations

18.

Roy, Nilotpal, Kenneth K. Takeuchi, Peter J. Bailey, et al.. (2016). PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance. Genes & Development. 30(24). 2669–2683. 67 indexed citations

19.

Carpenter, Eileen S., Kenneth K. Takeuchi, Christopher J. Halbrook, et al.. (2014). PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice. Gastroenterology. 147(6). 1405–1416.e7. 88 indexed citations

20.

DelGiorno, Kathleen E., Jason C. Hall, Kenneth K. Takeuchi, et al.. (2013). Identification and Manipulation of Biliary Metaplasia in Pancreatic Tumors. Gastroenterology. 146(1). 233–244.e5. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact